TAMADA: McCullough is over target again & reminds us what I & others (McCullough) have been saying, not only is mRNA vaccine on top of natural immunity of NO benefit, you may well end up in hospital,

see Tamada's study below but also see my prior early substack October 2022, near 1.5 years ago, that to layer vaccinal immunity ON TOP of natural immunity can have harmful effects, KRAMMER, RAW et al.

Booster Injections after Natural Immunity of Little Value

‘Booster Injections after Natural Immunity of Little Value

VENUS Study Demonstrates Unacceptably Low Vaccine Efficacy in Population with Prior COVID-19 Infection

PETER MCCULLOUGH, MD

By Peter A. McCullough, MD, MPH

COVID-19 vaccination was originally indicated to prevent the first case of SARS-CoV-2 infection. As vaccine mania set in across the globe, more and more patients who already recovered from the infection accepted multiple injections with the hope of “extra protection” or as a result of vaccine mandates.

Is it possible that repeated vaccine injections confer significant benefit in those with natural immunity? Tamada et al reported from the VENUS study carried out in Japan that additional boosters on top of natural immunity had very little value. The calculated vaccine efficacy was well below 50% for any episode of COVID-19 test positivity and there was no report of hospitalization or death benefit.

Tamada Y, Takeuchi K, Kusama T, Maeda M, Murata F, Osaka K, Fukuda H. Effectiveness of COVID-19 vaccines against infection in Japan: A test-negative study from the VENUS study. Vaccine. 2023 Aug 23;41(37):5447-5453. doi: 10.1016/j.vaccine.2023.07.035. Epub 2023 Jul 22. PMID: 37487845.

All of the vaccine manufacturers excluded patients with natural immunity from prior infection for a reason, they had little or no chance of benefit and a considerable opportunity for worsened side effects. While Tamada did not report on side effects, one would conclude in populations where >90% of patients have had COVID-19, vaccination offers little value.’

Raw et al.: "Previous COVID-19 infection but not Long-COVID associated with increased adverse events after Pfizer vaccination"; to layer COVID vaccine on recovered immunity is not good; see Krammer

Prior COVID-19 infection but not ongoing Long-COVID symptoms were associated with an increase in the risk of self-reported adverse events following BNT162b2/Pfizer vaccination.

DR. PAUL ALEXANDER

“Prior COVID-19 infection but not ongoing Long-COVID symptoms were associated with an increase in the risk of self-reported adverse events following BNT162b2/Pfizer vaccination.”

SOURCE 1:

Substack Alexander COVID News evidence-based medicine is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Subscribed

https://www.medrxiv.org/content/10.1101/2021.04.15.21252192v1

“Of 974 respondents (81% female, mean age 48), 265 (27%) reported previous COVID-19 infection. Within this group (symptoms median 8.9 months pre-vaccination), 30 (11%) complained of Long-COVID. The proportion reporting one moderate/severe symptom was higher in the previous COVID-19 group (56% v 47%, OR=1.5 [95%CI, 1.1–2.0], p=.009), with fever, fatigue, myalgia-arthralgia and lymphadenopathy significantly more common…

Prior COVID-19 infection but not ongoing Long-COVID symptoms were associated with an increase in the risk of self-reported adverse events following BNT162b2/Pfizer vaccination. COVID-19 illness-vaccination interval did not significantly influence AEs.”

SOURCE 2:

Krammer et al.

https://www.medrxiv.org/content/10.1101/2021.01.29.21250653v1

Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine